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ABSTRACT: 
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Background: Studies on longitudinal brain volume changes in patients with 
early-onset psychosis (EOP) are particularly valuable for understanding the 
neurobiological basis of brain abnormalities associated with psychosis. 
However, findings have not been consistent across studies in this population. 
We aimed to conduct a meta-analysis on progressive brain volume changes in 
children and adolescents with EOP. 
Methods: A systematic literature search of magnetic resonance imaging (MRI) 
studies comparing longitudinal brain volume changes in children and 
adolescents with EOP and healthy controls was conducted. The annualized 
rates of relative change in brain volume by region of interest (ROI) were used 
as raw data for the meta-analysis. The effect of age, sex, duration of illness, 
and specific diagnosis on volume change was also evaluated.  
Results: Five original studies with 156 EOP patients (mean age at baseline 
MRI in the five studies ranged from 13.3 to 16.6 years, 67.31% males) and 163 
age- and sex-matched healthy controls, with a mean duration of follow-up of 
2.46 years (range 2.02-3.40), were included. Frontal gray matter (GM) was the 
only region in which significant differences in volume change over time were 
found between patients and controls (Hedges’ g -0.435, 95% confidence 
interval (CI): -0.678 to -0.193, p<0.001). Younger age at baseline MRI was 
associated with greater loss of temporal GM volume over time in patients as 
compared with controls (p=0.005). Within patients, a diagnosis of schizophrenia 
was related to greater occipital GM volume loss over time (p=0.001). 
Conclusions: Compared with healthy individuals, EOP patients show greater 
progressive frontal GM loss over the first few years after illness onset. Age at 
baseline MRI and diagnosis of schizophrenia appear to be significant 
moderators of particular specific brain volume changes. 
Key words: brain volume; gray matter; early-onset psychosis; meta-analysis; 
MRI; longitudinal.  
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1. Introduction 
Recent meta-analyses assessing longitudinal brain changes over a 2- to 10-
year follow-up period in patients with adult-onset schizophrenia suggest 
progressive decreases over time in cortical gray matter (GM) volume compared 
with healthy controls (Fusar-Poli et al., 2013; Haijma et al., 2013; Olabi et al., 
2011; Vita et al., 2012). These changes seem to be even greater in patients 
with early-onset psychosis  (EOP, i.e., patients with psychotic symptoms 
appearing before the age of 18 years and diagnosed with psychotic disorder) 
(Gogate et al., 2001; Vita et al., 2012), especially during the first 1-3 years after 
the onset of psychotic symptoms (Arango et al., 2012; Brent et al., 2013).  
In particular, compared with healthy controls, patients with EOP –  both those 
with first-episode psychosis (FEP) and non-FEP patients – show greater 
progressive GM volume decreases over time in total GM volume (TGV), and 
frontal GM and parietal GM volumes (Arango et al., 2012; Gogtay et al., 2004b; 
Jacobsen et al., 1998; Rapoport et al., 1999; Reig et al., 2009a; Thompson et 
al., 2001). EOP patients also show greater decreases in cerebellar (Greenstein 
et al., 2011; Keller et al., 2003a), hippocampal (Giedd et al., 1999; Jacobsen et 
al., 1998; Johnson et al., 2013b; Mattai et al., 2011a; Nugent et al., 2007), and 
thalamic volume (James et al., 2002; Janssen et al., 2012; Rapoport et al., 
1997), and greater increases in lateral ventricle volume (Giedd et al., 1999; 
James et al., 2004; Rapoport et al., 1997).  
However, findings in EOP patients have not been consistent across longitudinal 
studies. One study reported loss of corpus callosum (CC) volume over time 
(Keller et al., 2003b), which was not reported in (Johnson et al., 2013a). Several 
studies showed greater progressive loss of temporal GM volume over time 
compared with healthy controls (Gogtay et al., 2004b; Jacobsen et al., 1998; 
James et al., 2004; Rapoport et al., 1999), but see (Arango et al., 2012). There 
were even two studies reporting an absence of progressive brain changes in 
patients over the first 2-3 years of follow-up (James et al., 2004; James et al., 
2002).  
Discrepant volumetric findings in young people may be at least partly 
attributable to different factors and conditions that moderate the detected 
pattern of structural brain changes, i.e., 1) differences in sex proportion 
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(Janssen et al., 2012; Lenroot et al., 2007), 2) age at onset (Vita et al., 2012), 3) 
duration of illness (Haijma et al., 2013), 4) duration of follow-up (Haijma et al., 
2013; Vita et al., 2012), 5) brain regions of interest (ROIs) under study (Arango 
et al., 2008), 6) use of voxel-based morphometry (VBM) versus ROI-based 
approaches (Giuliani et al., 2005), 7) exposure to lithium or antipsychotic 
treatment (Fusar-Poli et al., 2013; Hafeman et al., 2012; Haijma et al., 2013; Ho 
et al., 2011; Navari and Dazzan, 2009), 8) symptom presentation and severity 
(Arango et al., 2012; DeLisi et al., 1998; Nery et al., 2009; Strakowski et al., 
2002), and 9) diagnostic heterogeneity (Arango et al., 2008; Arango et al., 
2012). 
Childhood-onset schizophrenia (COS) is defined as schizophrenia with onset 
prior to age 13 years. Individuals with COS are reported to show a higher rate of 
pre-psychotic neurodevelopmental problems as compared with adolescent-
onset cases (Arango et al., 2008; Hollis, 1995). Cross-sectional and longitudinal 
studies report GM volume deficits in COS that could be considered an 
exaggeration of GM development reported in typically developing subjects 
(Burke et al., 2008; Greenstein et al., 2006; Thompson et al., 2001), while 
studies in patients with late-adolescent-onset and adult-onset forms of the 
disease (adult-onset schizophrenia – AOS) report less marked differences in 
parietal GM volume and more marked differences in the later maturing 
prefrontal and temporal cortices as compared with their childhood-onset 
counterparts (Janssen et al., 2014a; Rimol et al., 2010; Rimol et al., 2012). This 
is also true for first-episode non-schizophrenia patients (e.g., patients with early-
onset bipolar disorder) who are reported to show similar, albeit less marked and 
widespread, age-related GM volume abnormalities and trajectories than SSD 
patients (El-Sayed et al., 2010; Farrow et al., 2005; Janssen et al., 2014b; 
Janssen et al., 2008).This suggests a neurobiological continuum between EOP 
and adult-onset psychosis (AOP) (Arango et al., 2008), with the former following 
a more severe clinical and functional course (Bernardo and Bioque, 2014; 
Driver et al., 2013).  
In typically developing individuals, maturation of TGV includes an increase 
during childhood with a peak around puberty, followed by a sustained decrease 
during adolescence (Gogtay et al., 2004a). However, rate and amount of GM 
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loss varies by region and age, supposedly starting in the dorsal parietal cortices 
around puberty and then spreading rostrally over the frontal cortex (after 
reaching peak volume at 11-12 years of age) and caudally and laterally over the 
occipital, parietal, and finally the temporal cortex (after reaching peak volume at 
16-17 years of age) (Gogtay et al., 2004a) and the dorsolateral prefrontal 
cortex, which does not reach adult dimensions until the early 20s (Lenroot et al., 
2007). In fact, longitudinal trajectories suggest that the rate of cortical and 
hippocampal GM loss plateaus during adolescence (Giedd et al., 1999; Sporn 
et al., 2003). The pattern of morphological brain changes in EOP patients may 
thus be modulated by age (and thus stage of brain development) at illness 
onset.  
Studies on brain volume changes in children and adolescents with psychosis 
seem to be particularly valuable for understanding the neurobiological basis of 
the illness overall (Brent et al., 2013). However, to date, a meta-analysis on 
progressive brain volume changes in children and adolescents with EOP has 
never been conducted. 
The primary goal of the current meta-analysis was to examine to what extent 
EOP patients undergo progressive brain volume changes compared with 
healthy controls. We also aimed to assess the effect of factors potentially 
affecting brain volume change, such as age, male to female ratio, duration of 
illness, and specific diagnosis. 
 
2. Methods 
2.1. Selection procedures 
2.1.1. Search strategies 
Using the Preferred Reporting Items for Systematic Reviews and Meta-analyses 
(PRISMA) flow diagram for literature search, a systematic two-step literature 
search was conducted to identify appropriate studies (Moher et al., 2009). First, 
a PubMed, Web of Science, and Embase search was performed to detect 
putative longitudinal MRI studies in EOP. The search was conducted from 
inception through May 2014. The following search terms were used: “magnetic 
resonance imaging” (MRI) (OR “MRI” OR “neuroimaging”) AND “psychosis” (OR 
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“schizophrenia”) AND adolescent (OR “child”) AND “longitudinal” (OR 
“progressive” OR “follow-up”) NOT review, and combinations of the above 
terms. Second, the reference list of the selected articles was manually checked 
for any studies not identified by the computerized literature search. There was 
no language restriction. 
 
2.1.2. Selection criteria 
Studies were considered for review if they met the following hierarchical criteria: 
1) they were published as original peer-reviewed articles; 2) they compared 
patients with a diagnosis of psychotic disorder (according to DSM-IV, DSM-III-
R, or ICD-10) with age- and sex-matched healthy controls; 3) patients were 
younger than 18 years old at the beginning of the psychotic illness; 4) the 
studies had a longitudinal design (i.e., patients and controls were followed over 
a time period and underwent two or more MRI assessments); and 5) they used 
ROI volumetric analysis of structural MRI data (studies providing information on 
areas, volume estimation by means of an inadequate number of slices, VBM, 
cortical pattern matching, diffusion tensor imaging, tractography, or other 
techniques that do not provide brain volumetric data for a priori defined 
anatomical regions of interest were not included). 
Studies were excluded if 1) there were fewer than five subjects in the EOP 
group and/or the control group; 2) the data overlapped with those of another 
publication assessing the same ROIs, in which case the publication with the 
largest group size was selected; 3) the data did not contribute to an ROI 
included in the meta-analyses (meta-analyses were conducted when at least 3 
independent studies reported the volume of the specific ROI); and 4) the means 
and standard deviations (SD) of the baseline and follow-up volumes of the 
included ROIs were not reported (or could not be extracted from the reported 
data or retrieved from the authors).  
Supplementary Table 1 provides a summary of longitudinal MRI studies in EOP 
and the reason for exclusion from this meta-analysis as appropriate. 
 
2.1.3. ROI selection and data abstraction 
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The following ROIs were included in the meta-analysis: total brain volume 
(TBV), TGV, frontal GM volume, parietal GM volume, temporal GM volume, and 
occipital GM volume. For each of the ROIs, brain volume changes were 
extracted as the primary outcome. Specifically, volume was extracted in mL, 
and the mean and SD of the percentage change in volume was computed as 
follows: [(volume at follow-up – volume at baseline) / volume at baseline] * 100. 
Annualized rates of loss of brain volume were then estimated by dividing the 
percentage volume change over time in each study by the mean inter-scan 
interval (all included studies had a mean interval > 1 year). These were the raw 
data used for meta-analysis (see Supplementary Table 2 for details). 
When articles provided data for defined subgroups (for example, by sex or by 
left/right hemisphere), the data were combined (weighted by the sample size of 
each group) so that each study contributed only one datapoint per ROI to the 
meta-analysis. This was done in order to make the data from the different 
studies comparable. 
The data extracted from the studies also included author names, year of 
publication, number of participants, age at baseline, proportion of male 
participants, handedness, diagnosis, duration of illness (as the time from the 
reported age at onset to MRI acquisition), and duration of follow-up (as the 
mean interval between MRI scans). In instances where the primary outcome 
measures and/or the above-mentioned demographic/clinical data could not be 
retrieved from the original publication, the corresponding authors were 
contacted by e-mail.  
 
2.2. Statistical analysis 
Data were entered into an electronic database and analyzed with a quantitative 
meta-analytical approach using Comprehensive Meta-Analysis (CMA) Software 
version 2 (Biostat, Inc., Englewood, NJ) (Borenstein et al., 2005). 
The effect size was estimated by calculating Hedges’ unbiased g. Negative 
values reflected greater brain volume reduction in patients compared with 
controls from baseline to follow-up. Standardized effect sizes were combined to 
produce a single summary estimate using random-effects techniques based on 
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the method of maximum likelihood (DerSimonian and Laird, 1986). To limit the 
risk of false positive (type I) errors arising from multiple comparisons, we 
adjusted the p-value by dividing it by the number of meta-analyses conducted 
(corrected p = 0.0083 (0.05/6)).  
To assess the heterogeneity among study point estimates, we calculated the Q 
statistic, with magnitude of heterogeneity being evaluated using the I2 statistic (a 
measure of the proportion of variance in summary effect size attributable to 
heterogeneity) (Lipsey and Wilson, 2000).  
Publication bias was assessed by visually inspecting funnel plots and applying 
Egger’s regression test (Egger et al., 1997). In addition, we used Orwin’s fail-
safe N (Orwin, 1983). This generated the number of unpublished studies that 
would be needed to move estimates to a non-significant threshold. When the 
funnel plot or test statistics suggested publication bias, we used the Duval and 
Tweedie trim-and-fill method to estimate an effect size corrected for publication 
bias (Duval and Tweedie, 2000).  
The influence of demographic and clinical variables was tested using weighted 
linear meta-regression analyses (mixed effects regression, unrestricted 
maximum likelihood), with study effect size as the independent variable and 
either age (as mean age of patients at baseline MRI in years), sex (as 
percentage of male patients), duration of illness (as time from the reported age 
at onset to MRI acquisition in years), and specific diagnosis (as percentage of 
patients with a diagnosis of schizophrenia) as the dependent variables.  
 
3. Results 
3.1. Search results 
The initial literature search yielded 1047 studies. After removing 777 duplicates, 
270 potential studies were fully assessed. Of the 270 studies, 21 fulfilled the 
inclusion criteria. Of those, 16 met at least one exclusion criterion 
(Supplementary Table 1). The final meta-analysis database comprised five 
original independent studies (Arango et al., 2012; Gogtay et al., 2004b; James 
et al., 2004; Reig et al., 2009a; Sporn et al., 2003). The study by Gogtay and 
colleagues (Gogtay et al., 2004b) provided separate volumetric data for two 
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independent groups of EOP patients: COS and psychosis not otherwise 
specified (NOS). Thus, for purposes of this meta-analysis, they were considered 
two different studies. The overall sample was composed of 156 EOP patients 
and 163 healthy controls. The mean duration of follow-up was 2.46 years (range 
2.02 to 3.40). Figure 1 shows the flowchart of the systematic literature search 
strategy. 
  
FIGURE 1 ABOUT HERE 
 
3.2. Demographic characteristics 
The mean age of EOP patients in each of the five included studies ranged from 
13.3 to 16.6 years. The percentage of male patients in each of the five included 
studies ranged from 56.3% to 84.2%, with male patients outnumbering female 
patients overall (male patients n=105 (67.31%), female patients n=51 
(32.69%)). Of the 156 patients, 82 (52.6%) were experiencing their first episode 
of psychosis. Details of the included studies are shown in Table 1. 
 
TABLE 1 ABOUT HERE 
 
3.3. Results of the main meta-analysis 
Random effects analyses were conducted for 6 ROIs: TBV, TGV, frontal GM 
volume, parietal GM volume, temporal GM volume, and occipital GM volume. 
Results are presented in Table 2. 
After correction for multiple comparisons, greater frontal GM volume reductions 
over time were found in EOP patients compared with healthy controls (mean 
Hedges’ g -0.435, 95% confidence interval (CI): -0.678 to -0.193, corrected 
p<0.001). Figure 2 shows the forest plot for the meta-analysis of the three 
studies assessing longitudinal changes in frontal GM volume (Arango et al., 
2012; Reig et al., 2009a; Sporn et al., 2003).  
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TABLE 2 ABOUT HERE 
FIGURE 2 ABOUT HERE 
 
There were no significant differences between patients and controls in changes 
over time in TBV, TGV, parietal, temporal, or occipital GM volumes (all p-values 
> 0.05, except for occipital GM volume for which significant differences were 
found before correction for multiple comparisons (uncorrected p= 0.047)) (see 
Table 2). 
 
3.4. Publication bias, heterogeneity, and sensitivity analysis  
Statistically significant heterogeneity was detected for temporal (Q=9.607, 
I2=79.18%, p=0.008) and occipital (Q=11.893, I2=83.18%, p=0.003) GM 
volumes. Egger’s test indicated a presence of publication bias for TBV 
(p=0.010), TGV (p=0.049), and parietal GM volume (p=0.025). Indeed, trim-
and-fill adjustment showed that, after correction for publication bias, differences 
in parietal GM volume change over time between patients and controls were 
significant at the uncorrected level (mean Hedges’ g after trim-and-fill method -
0.369, 95% CI -0.560 to -0.138) (see Table 2). Frontal GM volume was the only 
measure for which neither significant heterogeneity nor publication bias was 
found. 
For each ROI, the modifying effects of age, male proportion, duration of illness, 
and diagnosis were investigated using meta-regression analyses. Two 
significant associations were found between these variables and effect size. 
First, mean age of patients at baseline MRI was associated with effect size in 
temporal GM, thus the younger the patient, the greater the loss of temporal GM 
volume over the follow-up period compared with the control group (Beta=1.425, 
95% CI: 0.427 to 2.423, p=0.005). Second, within patients, a diagnosis of 
schizophrenia was related to greater loss of occipital GM volume over the 
follow-up period (Beta= -0,013, 95% CI: -0,021 to -0,005, p=0.001). The effect 
of diagnosis (having schizophrenia vs. other psychotic disorders) on changes in 
TBV, TGV, and frontal, parietal, or temporal GM volume was not significant (all 
p-values > 0.05). The effects of sex (proportion of males) and duration of illness 
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on the effect size of volume changes in the assessed ROIs were not significant 
either. Supplementary Table 3 summarizes the meta-regression data. 
 
4. Discussion 
Findings from the present meta-analysis suggest that, compared with age- and 
sex-matched healthy controls, patients with EOP exhibit greater progressive 
loss in frontal GM, but not in TBV, TGV, parietal GM volume, temporal GM 
volume, or occipital GM volume over the first few years after illness onset. 
These results suggest that progressive cortical GM changes in EOP occur with 
regional specificity.  
Recent meta-analyses in adult patients with schizophrenia (Haijma et al., 2013; 
Olabi et al., 2012) have reported larger decreases over time in TGV, frontal GM 
volume, temporal GM volume, parietal GM volume, and occipital GM volume in 
patients relative to healthy controls. These results have been replicated in 
mixed samples of adolescent and adult patients with schizophrenia (Vita et al., 
2012) as well as in original studies in EOP patients (Arango et al., 2012; 
Jacobsen et al., 1998; Rapoport et al., 1999; Thompson et al., 2001). 
Nevertheless, these findings have not been consistent across studies (e.g., it 
has been reported that occipital GM volume shows a positive annualized 
percentage of change both in patients and controls (Vita et al., 2012). Even 
though our meta-analysis found a pattern of GM loss for TGV, frontal GM, 
parietal GM, and temporal GM for both EOP patients and controls, and occipital 
GM loss for patients only, that loss was significantly larger only in the frontal 
lobe for patients compared with controls. 
A type II error, i.e., a failure to detect an effect that is present, may underlie our 
regional-specific findings. In our study, the difference in volume loss over the 
follow-up period between patients and controls in both occipital GM and parietal 
GM showed a trend towards significance (p=0.047, and p=0.052, respectively). 
Indeed, after correction for publication bias, differences in parietal GM volume 
change reached statistical significance (although this finding did not survive 
multiple comparison correction, see Table 2). In this context, frontal GM would 
be merely the ROI that showed the most marked difference between patients 
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and controls during follow-up. This is congruent with findings in adult patients 
with schizophrenia showing the greatest effect size for frontal volume loss as 
compared with the other lobes (Haijma et al., 2013; Olabi et al., 2012; Vita et 
al., 2012). Furthermore, it is consistent with a recent study showing decreased 
frontal cortical thickness and increased sulcal width in adolescents with 
psychoses who were diagnosed with schizophrenia or bipolar disorder with 
psychotic symptoms after a two-year clinical follow-up when compared with 
controls (Janssen et al., 2014a). In addition, although our meta-analysis did not 
find a significantly greater loss of temporal GM volume in EOP patients 
compared with controls, it showed that mean age of patients at baseline MRI 
was associated with the effect size in this ROI, thus the younger the patient, the 
greater the loss of temporal GM volume over the follow-up period compared 
with controls. This effect of age could partly explain the heterogeneous temporal 
GM volume findings in previous studies. 
Some of the discrepancies between previous results of meta-analyses of 
longitudinal MRI studies, e.g., (Haijma et al., 2013; Olabi et al., 2012; Vita et al., 
2012), and our findings could be partially explained by the particular 
developmental stage of patients included in our study and their region-related 
brain development pattern. The mean age of patients of the five studies 
included in the present meta-analysis ranged from 13.3 to 16.6 years. At that 
developmental stage, frontal and occipital poles are likely to be the ones that 
are most affected and show greater differences compared with controls, as they 
are actually undergoing active maturation at these ages, while the temporal lobe 
shows a later maturation pattern (Arango et al., 2008). Our results would thus 
support the hypothesis that, in EOP, there is an exaggeration of the normal 
brain GM loss that takes place in adolescence, a physiological process in which 
volume loss (Gogtay et al., 2004a) and flattening of cortical GM appear to be 
greatest in the frontal and occipital regions as compared with other cortical 
regions (Aleman-Gomez et al., 2013). In fact, purely adolescent EOP cohorts 
are reported to show frontal (but not parietal or temporal) GM volume deficits 
compared with age-matched healthy individuals, both in cross-sectional 
(Moreno et al., 2005) and longitudinal studies (Reig et al., 2009a).  Of note, 
mean age at scan of the patients of the five studies included in this meta-
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analysis (13.3 to 16.6 years) should not be considered equal to mean age at 
onset of psychosis. Indeed, duration of illness (and thus patient age at onset) 
varied among studies (from 0.27 years in adolescent-onset psychosis studies to 
5.50 years in COS studies). Thus, age-related findings in our study could be 
potentially confounded by a time-of-measurement effect. That said, the effect of 
duration of illness on brain volume changes over the follow-up period was not 
significant for any of the ROIs.  
The mechanisms that lead to an exaggeration of progressive GM loss in EOP 
patients may include anomalous neurodevelopmental processes (most likely 
glial and vascular rather than purely neuronal changes (Rapoport and Gogtay, 
2008), excessive and aberrant synaptic pruning with a reduction of neuropil 
rather than a deficit in the total number of neurons (Cannon et al., 2014; 
Whitford et al., 2007), aberrant neurogenesis, axonal growth, myelinization, or 
synaptogenesis, and GM disorganization (Mauney et al., 2013; van Os et al., 
2010)), dopamine sensitization (Howes and Murray, 2014), epigenetic changes 
(van Os et al., 2010), oxidative damage (Fraguas et al., 2012), and pro-
inflammatory status (Garcia-Bueno et al., 2014). According to the  two-hit 
hypothesis, early GM loss in EOP patients would be due to the interaction of 
genetic or very early vulnerabilities (first hit) with a second hit around 
adolescence (typical age of onset of psychosis) (Brown, 2011; Maynard et al., 
2001). These hits could trigger or maintain pathophysiological mechanisms that 
would lead to abnormal brain development and may pre-date illness onset 
(Rapoport et al., 2012). The two-hit hypothesis appears to be supported by 
prospective neuroimaging studies of non-psychotic full siblings of COS patients. 
These individuals show a pattern of frontal and temporal GM deficits in 
childhood that appear to normalize by the time they reach late adolescence 
(Raznahan et al., 2011). The normalization of cortical GM loss would represent 
a resilient phenotype in siblings. Early GM loss in siblings would be due to 
genetic vulnerabilities (first hit), but the second hit around adolescence would 
be absent or overcome by a plastic response of normalization of the early GM 
abnormalities. Conversely, EOP patients would represent a group in which the 
two-hits are present so they do not develop this resilient phenotype (Rapoport 
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et al., 2012). This observation was recently replicated in a non-overlapping 
sample of healthy siblings and matched healthy controls (Mattai et al., 2011b).  
There are several limitations to this study that should be taken into account 
when interpreting the results. Firstly, we assessed patients with EOP, which is a 
diagnostically heterogeneous group. The small sample size limited the capacity 
of analysis for a specific diagnosis, such as schizophrenia. To reduce the 
consequences of this limitation, we conducted a meta-regression with specific 
diagnosis (percentage of patients with a diagnosis of schizophrenia) as the 
dependent variable. Within the group of EOP patients, a diagnosis of 
schizophrenia was related only to greater loss of occipital GM volume during 
follow-up, while effect of a diagnosis of schizophrenia on the other ROIs was 
not significant. Although the pioneering studies assessing progressive cortical 
loss in COS as compared with other childhood-onset psychoses suggested that 
progressive cortical loss may be diagnostically specific to the former group 
(Gogtay et al., 2004b), our results suggest that differences between 
schizophrenia and affective psychosis are more quantitative than qualitative, 
with observed morphometric measures for bipolar patients positioned between 
healthy controls and schizophrenia patients (Arango et al., 2014). Since some 
of these brain abnormalities seem to predict outcome, they may represent a 
marker of severity rather than of specific psychosis diagnosis. Indeed, 
excessive GM loss in the early stages of psychotic illness may be considered a 
marker of poorer prognosis (e.g., it has been associated with longer duration of 
hospitalization during follow-up and with less improvement in psychotic 
symptoms) (Arango et al., 2012). In this sense, the schizophrenia finding may 
be an epiphenomenon driven by severity and/or medication (Arango et al., 
2014).  
Secondly, within the group of EOP patients, we did not distinguish between 
childhood-onset (i.e., onset before 13 years of age) and adolescent-onset cases 
and, given the limited sample size, we did not conduct specific subanalyses for 
childhood-onset patients (who seem to follow a clinical and neurobiological 
continuum with the adolescent- and adult-onset cases (Arango et al., 2008; 
Driver et al., 2013)).  
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Thirdly, it has been suggested that progressive GM volume decreases in 
schizophrenia patients are associated with exposure to antipsychotic treatment 
(Fusar-Poli et al., 2013; Haijma et al., 2013; Vita et al., 2012). However, 
antipsychotic dose over the follow-up period was not available for 3 out of the 5 
studies included in the meta-analysis. This is relevant because young people 
may be especially sensitive to antipsychotic-related adverse effects (e.g., 
extrapyramidal side effects, sedation, prolactin elevation, weight gain) (Kumra 
et al., 2008), and it is not known if the heightened sensitivity also moderates the 
putative relationship between antipsychotic drugs and brain volume changes. 
However, a recent study examining lobar cortical thickness and surface area 
width in healthy controls, EOP-schizophrenia and EOP-bipolar disorder with 
psychotic symptoms found no within-patient correlation between anatomical 
variation and dose of chlorpromazine equivalents used (Janssen et al., 2014a).  
Fourthly, although data annualization allows comparison between studies, it 
makes the assumption that brain volume loss is equivalent over all years of 
follow-up. However, it is unlikely that this loss is linear over time (Weinberger 
and McClure, 2002).  
Fifthly, different brain imaging acquisition and processing techniques may have 
an impact on observed effect sizes. A study assessing the increase in variability 
when combining volumetric data from different scanners showed that occipital 
lobe volumes had greater intersite coefficient of variation than frontal, parietal, 
or temporal lobes (Reig et al., 2009b). Although this may be due to a size effect, 
i.e., small variations in smaller regions have a greater effect than small 
variations in larger regions, significant heterogeneity in temporal GM volume 
and occipital GM volume may be  a consequence, at least in part, of greater 
intersite coefficient of variation. Furthermore, we did not control for slice 
thickness of MRI scans. In the meta-analysis by Vita and colleagues, slice 
thickness of MRI scans was a significant moderator of effect size for whole 
brain and superior temporal gyrus GM, indicating more evident differences 
between patients and controls detected in technologically more sophisticated 
studies (Vita et al., 2012). That said, all but one of the studies included in this 
meta-analysis used the same slice thickness (i.e., 1.5 mm).  
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Sixthly, we were not able to investigate the effect of left/right asymmetry. This is 
a controversial topic. The meta-analysis by Vita and colleagues reported that 
progressive cortical changes more markedly affect the left hemisphere (Vita et 
al., 2012). However, the meta-analysis by Haijma and colleagues concluded 
that significant differences in effect sizes between the left and right hemisphere 
were observed only for the planum temporale, without significant effects for 
frontal, parietal, or occipital regions (Haijma et al., 2013).  Moreover, including 
separate left and right measures in this meta-analysis would have resulted in a 
need to increase the number of comparisons with a derived increased risk of 
finding false positive associations.  
Seventhly, effect of intelligence quotient (IQ) on brain volume changes was not 
investigated. The largest cross-sectional meta-analysis of brain volume in adult 
schizophrenia patients did not find a significant moderating effect of IQ on brain 
volume differences between patients and controls (Haijma et al., 2013). 
In conclusion, this meta-analysis revealed that, during the first few years after 
illness onset, children and adolescents with EOP show greater progressive 
frontal GM loss compared with healthy controls. Future studies should focus on 
the neurobiological underpinnings of these pathologic progressive brain 
changes. The correlates of volume changes at cellular and network levels and 
the study of neurodevelopmental trajectories associated with different psychotic 
disorders may be promising areas of research for developing new therapeutic 
tools. 
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Table S1. Summary of longitudinal MRI studies in EOP 
Author, Year 
Finally 
included in 
the meta-
analysis 
Reason for exclusion 
(Arango et al., 2012) Yes NA 
(Clark et al., 2010) No No contribution to finally included ROIs 
(Fraguas et al., 2012) No Duplicated data 
(Frazier et al., 1996) No Duplicated data 
(Giedd et al., 1999) No Duplicated data 
(Gogtay et al., 2004)  Yes NA 
(Greenstein et al., 2011) No No contribution to finally included ROIs 
(Jacobsen et al., 1998) No No means/SD 
(James et al., 2002) No No means/SD 
(James et al., 2004) Yes NA 
(Johnson et al., 2013a) No No contribution to finally included ROIs 
(Johnson et al., 2013b) No No means/SD 
(Keller et al., 2003a) No Duplicated data 
(Keller et al., 2003b) No Duplicated data 
(Mattai et al., 2011) No Duplicated data 
(Nugent et al., 2007) No Duplicated data 
(Parellada et al., 2011) No Duplicated data 
(Rapoport et al., 1997) No Duplicated data 
(Rapoport et al., 1999) No Duplicated data 
(Reig et al., 2009) Yes NA 
(Sporn et al., 2003) Yes NA 
Abbreviations: Duplicated data: The data overlapped with those of another publication 
assessing the same ROIs, in which case the publication with the largest group size was 
selected. EOP: Early-onset psychosis. MRI: Magnetic resonance imaging. NA: Not applicable. 
No contribution to finally included ROIs: data did not contribute to an ROI included in the meta-
analyses (meta-analyses were conducted when at least 3 independent studies reported the 
volume of the specific ROI). No means/SD: Means and standard deviations of the baseline and 
follow-up volumes of the included ROIs were not reported. ROIs: Regions of interest. 
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Table S2. Data abstraction for brain volume by ROI 
Brain 
región 
(ROI) 
Author, 
Year 
Mean 
diff. Pt 
SD 
diff. 
Pt 
Mean 
diff. C 
SD diff. 
C 
Mean rel. 
Ch. % Pt 
SD rel. 
Ch. Pt 
Mean 
rel. Ch. 
% C 
SD rel. 
Ch. C 
Mean 
adj. 
rel. 
Ch. Pt 
SD adj. 
rel. Ch. 
Pt 
Mean 
adj. rel. 
Ch. C 
SD adj. rel. 
Ch. C 
TBV 
Sporn, 2003 -27.3 26.51 -10.3 27.23 -2.51 8.03 -0.92 8.14 -0.74 4.36 -0.27 4.41 
James, 2004 18.4 40.12 3.37 17.17 1.38 5.04 0.26 4.75 0.65 3.47 0.12 3.27 
Gogtay, 2004 
(Psych NOS) 
-4.12 41.27 -5.15 20.45 -0.39 1.27 -0.45 6.03 -0.15 0.79 -0.17 3.74 
TGV 
Sporn, 2003 -35.9 17.79 -16.2 16.29 -5.17 13.63 -2.25 6.07 -1.52 7.39 -0.66 3.29 
Gogtay, 2004 
(Psych NOS) 
-3.91 25.22 -11.45 14.24 -0.57 1.50 -1.53 5.21 -0.22 0.93 -0.59 3.23 
Reig, 2009 -12.62 24.57 -12.87 16.36 -1.53 4.39 -1.52 5.63 -0.76 3.09 -0.75 3.96 
Arango, 2012 -32.78 14.25 -14.5 12.4 -3.89 11.29 -1.70 4.24 -1.83 7.74 -0.80 2.91 
Frontal 
GM 
volume 
Sporn, 2003 -13.6 5.87 -8.5 4.84 -6.38 9.32 -3.81 3.24 -1.88 5.05 -1.12 1.76 
Reig, 2009 -4.6 3.77 -1.64 2.42 -2.87 3.63 -1.01 1.90 -1.42 2.55 -0.50 1.33 
Arango, 2012 -6.55 2.89 -1.5 2.53 -4.12 5.19 -0.92 1.98 -1.93 3.56 -0.43 1.35 
Parietal Sporn, 2003 -7.4 3.01 -5.4 2.97 -6.55 6.96 -4.50 2.71 -1.93 3.78 -1.32 1.47 
29 
GM 
volume 
Reig, 2009 -3.24 2.98 -3.52 2.49 -2.55 2.87 -2.68 2.17 -1.26 2.02 -1.33 1.53 
Arango, 2012 -8.04 2.76 -4.5 2.47 -6.13 7.02 -3.40 2.15 -2.88 4.81 -1.60 1.47 
Temporal 
GM 
volume 
Sporn, 2003 -5.10 4.79 -0.9 3.94 -2.83 3.80 -0.49 2.90 -0.83 2.06 -0.14 1.57 
Reig, 2009 -0.85 3.12 -3.21 2.38 -0.54 0.68 -1.99 1.88 -0.27 0.48 -0.99 1.32 
Arango, 2012 -6.80 3.27 -4.3 2.45 -4.12 5.29 -2.63 1.91 -1.93 3.63 -1.23 1.31 
Occipital 
GM 
volume 
Gogtay, 2004 
(Psych NOS) 
1.27 3.01 1.58 2.05 2.12 1.64 2.31 2.48 0.82 1.02 0.89 1.54 
Gogtay, 2004 
(COS) 
-2.54 3.36 1.58 2.05 -3.95 3.17 2.31 2.48 -1.57 2.00 0.89 1.57 
Reig, 2009 -5.16 3.62 -0.18 2.7 -5.52 5.34 -0.19 2.78 -2.73 3.76 -0.09 1.96 
Abbreviations: adj. rel. Ch.: adjusted relative change (annualized rates of loss of brain volume). C: control. COS: childhood-onset schizophrenia. diff.: 
difference. GM: gray matter. Psych NOS: psychosis not otherwise specified. Pt: patients. Rel. Ch.: relative change (volume at follow-up – volume at baseline) / 
volume at baseline). ROI: region of interest. SD: standard deviation. TBV: total brain volume. TGV: total GM volume. 
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Table S3. Summary of the meta-regressions 
Brain region 
(ROI) 
Moderator 
Beta Q p 
Mean 95% CI   
TBV 
Mean age of patients at initial MRI (years) 0.03 -0.228 0.289 0.053 0.818 
Males (%) 0 -0.027 0.027 0 0.987 
Duration of illness -0.049 -0.263 0.165 0.202 0.653 
SCZ (%) 0 -0.007 0.006 0.013 0.910 
TGV 
Mean age of patients at initial MRI (years) -0.107 -0.393 0.179 0.537 0.464 
Males (%) 0.008 -0.008 0.024 0.936 0.333 
Duration of illness 0.023 -0.071 0.478 0.229 0.633 
SCZ (%) -0.002 -0.009 0.004 0.440 0.570 
Frontal GM 
Mean age of patients at initial MRI (years) -0.428 -1.417 0.561 0.720 0.396 
Males (%) 0.012 -0.014 0.038 0.781 0.377 
Duration of illness 0.079 -0.042 0.199 1.650 0.199 
31 
SCZ (%) 0.006 -0.003 0.014 1.622 0.203 
Parietal GM 
Mean age of patients at initial MRI (years) 0.328 -0.653 1.309 0.429 0.513 
Males (%) 0.015 -0.011 0.041 1.329 0.249 
Duration of illness 0.009 0.111 0.129 0.020 0.887 
SCZ (%) 0 -0.008 0.009 0.009 0.924 
Temporal GM 
Mean age of patients at initial MRI (years) 1.425 0.427 2.423 7.829 0.005 
Males (%) 0.030 -0.048 0.107 0.559 0.455 
Duration of illness -0.126 -0.484 0.231 0.478 0.489 
SCZ (%) -0.010 -0.034 0.015 0.561 0.454 
Occipital GM 
Mean age of patients at initial MRI (years) -0.237 -0.553 0.078 2.170 0.141 
Males (%) 0.017 -0.025 0.058 0.617 0.432 
Duration of illness 0.131 -0.017 0.279 3.027 0.082 
SCZ (%) -0.013 -0.021 -0.005 10.804 0.001 
Abbreviations: CI: confidence interval. GM: gray matter volume. MRI: magnetic resonance imaging. ROI: region of interest. SCZ: 
schizophrenia. TBV: total brain volume. TGV: total gray matter volume. 
 
  
